Schedule 13G ownership disclosure

Evommune Inc

Common Stock, $0.0001 par value per share · CUSIP: 30054Y107

Event date: 2025-11-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Andera Partners

    Shares: 1,897,362.00 · Class: 6.0%

  • BioDiscovery 6 FPCI

    Shares: 1,897,362.00 · Class: 6.0%

  • Stephane Bergez

    Shares: 1,897,362.00 · Class: 6.0%

  • Francois Xavier Mauron

    Shares: 1,897,362.00 · Class: 6.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001757283-25-000005
Form type
SCHEDULE 13G
Filer
Andera Partners
CIK
CIK 1757283
Filed
Nov 17, 2025
Reporting period
Nov 07, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub